AAAAAA

   
Results: 1-9 |
Results: 9
CEREBROSPINAL-FLUID TAU-PROTEIN IS NOT ELEVATED IN HIV-ASSOCIATED NEUROLOGIC DISEASE IN HUMANS
Authors: ELLIS RJ SEUBERT P MOTTER R GALASKO D DEUTSCH R HEATON RK HEYES MP MCCUTCHAN JA GRANT I
Citation: Rj. Ellis et al., CEREBROSPINAL-FLUID TAU-PROTEIN IS NOT ELEVATED IN HIV-ASSOCIATED NEUROLOGIC DISEASE IN HUMANS, Neuroscience letters, 254(1), 1998, pp. 1-4
HIGH CEREBROSPINAL-FLUID TAU AND LOW AMYLOID BETA-42 LEVELS IN THE CLINICAL-DIAGNOSIS OF ALZHEIMER-DISEASE AND RELATION TO APOLIPOPROTEIN-EGENOTYPE
Authors: GALASKO D CHANG L MOTTER R CLARK CM KAYE J KNOPMAN D THOMAS R KHOLODENKO D SCHENK D LIEBERBURG I MILLER B GREEN R BASHERAD R KERTILES L BOSS MA SEUBERT P
Citation: D. Galasko et al., HIGH CEREBROSPINAL-FLUID TAU AND LOW AMYLOID BETA-42 LEVELS IN THE CLINICAL-DIAGNOSIS OF ALZHEIMER-DISEASE AND RELATION TO APOLIPOPROTEIN-EGENOTYPE, Archives of neurology, 55(7), 1998, pp. 937-945
MUTANT PRESENILINS OF ALZHEIMERS-DISEASE INCREASE PRODUCTION OF 42-RESIDUE AMYLOID BETA-PROTEIN IN BOTH TRANSFECTED CELLS AND TRANSGENIC MICE
Authors: CITRON M WESTAWAY D XIA WM CARLSON G DIEHL T LEVESQUE G JOHNSONWOOD K LEE M SEUBERT P DAVIS A KHOLODENKO D MOTTER R SHERRINGTON R PERRY B YAO H STROME R LIEBERBURG I ROMMENS J KIM S SCHENK D FRASER P HYSLOP PS SELKOE DJ
Citation: M. Citron et al., MUTANT PRESENILINS OF ALZHEIMERS-DISEASE INCREASE PRODUCTION OF 42-RESIDUE AMYLOID BETA-PROTEIN IN BOTH TRANSFECTED CELLS AND TRANSGENIC MICE, Nature medicine, 3(1), 1997, pp. 67-72
CSF LEVELS OF A-BETA-432 AND TAU AS AIDS TO DIAGNOSING ALZHEIMERS-DISEASE
Authors: GALASKO D SEUBERT P MOTTER R SCHENK D KHOLODENKO D LIEBERBURG I CHANG L MILLER B CLARK C KAYE J CAMICIOLI R KNOPMAN D GREEN RC THOMAS R KERTILES L BOSS M
Citation: D. Galasko et al., CSF LEVELS OF A-BETA-432 AND TAU AS AIDS TO DIAGNOSING ALZHEIMERS-DISEASE, Neurology, 48(3), 1997, pp. 63008-63008
ASSESSMENT OF CSF LEVELS OF TAN PROTEIN IN MILDLY DEMENTED PATIENTS WITH ALZHEIMERS-DISEASE
Authors: GALASKO D CLARK C CHANG L MILLER B GREEN RC MOTTER R SEUBERT P
Citation: D. Galasko et al., ASSESSMENT OF CSF LEVELS OF TAN PROTEIN IN MILDLY DEMENTED PATIENTS WITH ALZHEIMERS-DISEASE, Neurology, 48(3), 1997, pp. 632-635
AMYLOID PRECURSOR PROTEIN PROCESSING AND A-BETA(42) DEPOSITION IN A TRANSGENIC MOUSE MODEL OF ALZHEIMER-DISEASE
Authors: JOHNSONWOOD K LEE M MOTTER R HU K GORDON G BARBOUR R KHAN K GORDON M TAN H GAMES D LIEBERBURG I SCHENK D SEUBERT P MCCONLOGUE L
Citation: K. Johnsonwood et al., AMYLOID PRECURSOR PROTEIN PROCESSING AND A-BETA(42) DEPOSITION IN A TRANSGENIC MOUSE MODEL OF ALZHEIMER-DISEASE, Proceedings of the National Academy of Sciences of the United Statesof America, 94(4), 1997, pp. 1550-1555
THE TAU-PROTEIN IN HUMAN CEREBROSPINAL-FLUID IN ALZHEIMERS-DISEASE CONSISTS OF PROTEOLYTICALLY DERIVED FRAGMENTS
Authors: JOHNSON GVW SEUBERT P COX TM MOTTER R BROWN JP GALASKO D
Citation: Gvw. Johnson et al., THE TAU-PROTEIN IN HUMAN CEREBROSPINAL-FLUID IN ALZHEIMERS-DISEASE CONSISTS OF PROTEOLYTICALLY DERIVED FRAGMENTS, Journal of neurochemistry, 68(1), 1997, pp. 430-433
ELEVATION OF CSF-TAU IN EARLY-STAGE ALZHEIMERS-DISEASE
Authors: SEUBERT P MOTTER R SCHENK D GREEN R CHANG L MILLER B CLARK C GALASKO D
Citation: P. Seubert et al., ELEVATION OF CSF-TAU IN EARLY-STAGE ALZHEIMERS-DISEASE, Neurology, 46(2), 1996, pp. 5001-5001
REDUCTION OF BETA-AMYLOID PEPTIDE(42), IN THE CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMERS-DISEASE
Authors: MOTTER R VIGOPELFREY C KHOLODENKO D BARBOUR R JOHNSONWOOD K GALASKO D CHANG L MILLER B CLARK C GREEN R OLSON D SOUTHWICK P WOLFERT R MUNROE B LIEBERBURG I SEUBERT P SCHENK D
Citation: R. Motter et al., REDUCTION OF BETA-AMYLOID PEPTIDE(42), IN THE CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMERS-DISEASE, Annals of neurology, 38(4), 1995, pp. 643-648
Risultati: 1-9 |